Indian healthcare sector transforms as pharmaceuticals step beyond traditional roles to make advanced treatments more accessible and affordable.
Telangana launches a new cancer drug plant, inaugurated by IT and Industries Minister Duddilla Sridhar Babu, which aims to boost the production of generic cancer drugs that will decrease the dependence on imports
Sun Pharma's latest acquisition of Organon is worth 12 billion, which raises the Mergers and Acquisitions activity in India for the next four years
India's Unregistered IVF Clinics could soon find it difficult to continue operations as the Centre has tightened IVF rules.
The Ebola death toll in the Democratic Republic of Congo has crossed 500, marking another major setback in the country's fight against the deadly virus.
India hosts the BRICS Heads in Guwahati, chaired by the Narcotics Control Bureau, and anti-drug agencies from BRICS nations to address the rising concerns over drug trafficking and substance abuse globally
Granules India secures first-to-file status for their drug Lumryz, which belongs to the complex generic drug category and is a cure for narcolepsy, a neurological disorder that affects the brain's ability to regulate sleep
The new study from TATA Memorial has found ou that papaya leaf extracts are capable of reducing chemo side effects like reduced platelet counts and bleeding associated with it
Glenmark has expanded its presence in the US pharmaceutical market with the launch of its Fast-Acting Schizophrenia Injection, a generic version of Olanzapine for Injection, 10 mg/vial.
The Indian government has taken a major step to improve digital healthcare with the launch of the digital service, called the Bharat Health Terminology Service (BHTS).
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")